Marinus Pharmaceuticals Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2024 to a ratio of 8.51, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the third quarter 2024. Average receivable collection period, for the Marinus Pharmaceuticals Inc in Sep 30 2024 quarter, has decreased to 43 days, compared to 46 days, in the Jun 30 2024 quarter.

If we take a look into Healthcare sector 413 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2024 from 2082 to 2756.

What is Receivable Turnover Ratio?
What is Marinus Pharmaceuticals Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

MRNS Receivables Turnover Ratio	(Sep 30 2024) III. Quarter	(Jun 30 2024) II. Quarter	(Mar 31 2024) I. Quarter	(Dec 31 2023) IV. Quarter	(Sep 30 2023) III. Quarter
Y / Y Receivable Change	-10.3 %	-34.37 %	-69.96 %	-37 %	25.99 %
Y / Y Revenue Change	16.39 %	32.48 %	-26.02 %	0.39 %	213.59 %
Receivable Turnover Ratio (TTM)	8.51	7.95	6.65	4.92	4.49
MRNS's Total Ranking	# 2756	# 2082	# 2206	# 2912	#
Accounts Receivable average collection period days	43	46	55	74	81
Seq. Receivable Change	11.79 %	-2.22 %	-12.15 %	-6.59 %	-18.21 %
Seq. Revenue Change	6.02 %	4.91 %	6.8 %	-2.02 %	20.67 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 128
Healthcare Sector	# 414
Overall Market	# 2756

Receivable Turnover Ratio Statistics
High	Average	Low
0.26	0.16	0.11
(Sep 30 2024)		(Sep 30 2021)

MRNS Company Profile • Back to MRNS Efficiency Comparisons • Compare MRNS Receivables Turnover Ratio to its Competitors

Financial Statements
Marinus Pharmaceuticals Inc 's Accounts Receivable	$ 4 Millions	Visit MRNS's Balance sheet
Marinus Pharmaceuticals Inc 's Sales TTM	$ 31 Millions	Visit MRNS's Income Statement
Sources of MRNS's Revenues		Visit MRNS's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
MRNS's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
MRNS's Growth Rates	MRNS's Roa	MRNS's Inventory Turnover Ratio	MRNS's Dividend Comparisons
MRNS's Profitability Ratios	MRNS's Roi	MRNS's Asset Turnover Ratio	MRNS's Dividend Growth
MRNS's Valuation Ratios	MRNS's Roe	MRNS's Financial Strength Ratios	MRNS's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2024, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2024	Receivable at quarter ending Sep 30 2024
U S Physical Therapy Inc	22.39	$ 645.699 Millions	$ 28.841 Millions
Bespoke Extracts Inc	22.31	$ 1.080 Millions	$ 0.048 Millions
Cytomx Therapeutics Inc	22.28	$ 126.617 Millions	$ 5.684 Millions
One World Products Inc	22.21	$ 0.003 Millions	$ 0.000 Millions
Innovative Eyewear Inc	21.65	$ 1.562 Millions	$ 0.072 Millions
Ginkgo Bioworks Holdings Inc	21.39	$ 217.951 Millions	$ 10.188 Millions
Ethema Health Corporation	21.31	$ 5.675 Millions	$ 0.266 Millions
Co diagnostics Inc	19.94	$ 7.321 Millions	$ 0.367 Millions
Nutriband Inc	19.66	$ 2.022 Millions	$ 0.103 Millions
Innoviva Inc	19.25	$ 413.572 Millions	$ 21.480 Millions
Medinotec Inc	19.03	$ 8.385 Millions	$ 0.441 Millions
Innovage Holding Corp	18.97	$ 786.512 Millions	$ 41.471 Millions
Kiniksa Pharmaceuticals International Plc	18.60	$ 384.098 Millions	$ 20.650 Millions
Pulmatrix Inc	18.56	$ 10.005 Millions	$ 0.539 Millions
Milestone Scientific Inc	18.54	$ 8.862 Millions	$ 0.478 Millions
Hookipa Pharma inc	17.97	$ 49.999 Millions	$ 2.782 Millions
Vireo Growth Inc.	17.70	$ 98.534 Millions	$ 5.568 Millions
Macrogenics Inc	17.38	$ 141.329 Millions	$ 8.132 Millions
Silence Therapeutics Plc	17.27	$ 43.010 Millions	$ 2.490 Millions
Talkspace Inc	16.98	$ 179.853 Millions	$ 10.591 Millions
Scorpius Holdings inc	16.51	$ 10.044 Millions	$ 0.608 Millions
Arvinas Inc	16.48	$ 161.100 Millions	$ 9.775 Millions
Stablecoin Development Corporation	16.33	$ 11.199 Millions	$ 0.686 Millions
Nexalin Technology Inc	16.24	$ 0.162 Millions	$ 0.010 Millions
Inmed Pharmaceuticals Inc	16.11	$ 4.284 Millions	$ 0.266 Millions
Precipio inc	16.07	$ 17.411 Millions	$ 1.084 Millions
Sangamo Therapeutics Inc	15.97	$ 52.291 Millions	$ 3.274 Millions
Icu Medical Inc	14.80	$ 2,340.754 Millions	$ 158.125 Millions
Biofrontera Inc	14.26	$ 61.432 Millions	$ 4.308 Millions
Valion Bio Inc	14.02	$ 0.957 Millions	$ 0.068 Millions

Date modified: 2026-08-29T17:19:29+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.